Last $8.33 USD
Change Today +0.07 / 0.85%
Volume 452.2K
OSUR On Other Exchanges
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Anthony Zezzo II

Executive Vice President of Marketing and Sales, OraSure Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Mr. Anthony Zezzo, II, also known as Tony, has been an Executive Vice President of Marketing and Sales at OraSure Technologies, Inc. since January 4, 2011. Mr. Zezzo has overall responsibility for the OraSure Technologies Inc.'s global marketing and sales operations, which includes the domestic and international sales teams for its infectious disease and substance abuse businesses, marketing, and client services/customer care. He joined OraSure as an accomplished sales ...

Read Full Background

Corporate Headquarters*

220 East First Street
Bethlehem, Pennsylvania 18015

United States

Phone: 610-882-1820
Fax: 610-882-1830

Board Members Memberships*

There is no Board Members Memberships data available.


Unknown/Other Education
Grove City College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$362,000

Stock Options*

Restricted Stock Awards$79,637
Exercisable Options100,447
Exercisable Options Value$29,349
Unexercisable Options83,678
Unexercisable Options Value$10,901
Total Value of Options$40,250
Total Number of Options184,125

Total Compensation*

Total Annual Cash Compensation$553,320
Total Short Term Compensation$362,000
Other Long Term Compensation$79,637
Total Calculated Compensation$752,381
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSUR:US $8.33 USD +0.07


Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
John A. Kraeutler Chief Executive Officer and Director
Meridian Bioscience, Inc.
Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
Paul Averback M.D., DABPFounder, Chairman, Chief Executive Officer, President and Member of Communications Committee
Nymox Pharmaceutical Corporation
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORASURE TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at